EISAI INC. for EISAI INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Regulatory and legislative health care issues: 340B program; Value-based drug contracting; Proposals related to drug pricing; Issues related to global pharmaceutical supply chain; Bayh-Dole march-in rights; Medicare Part D Negotiation/Non-interference repeal bills; S. 4348/H.R.7667, Prescription Drug User Fee Act (PDUFA) reauthorization; S. 908/ H.R. 2139, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; H.R.7667, Food and Drug Amendments of 2022; S.4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDASLA Act).
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
Medicare/Medicaid MMM
Policies to enhance patient access to medicines in Medicaid including rebate, waiver policy and funding issues; Access to medicines in Medicare; Centers for Medicare and Medicaid Services (CMS) National Coverage Determination (NCD) for Alzheimers therapies; Rebates and Medicare Part D - provisions related to the HHS-OIG Rebate Safe Harbor; Co-pay accumulators; Medicare Part D redesign proposals; Notice of Benefit and Payment Parameters; and Proposed Medicaid regulations; H.R. 5376, Inflation Reduction Act/FY2022 Budget Reconciliation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
Trade (domestic/foreign) TRD
Issues related to pharmaceutical IP and supply chain; World Trade Organization waiver of Trade-Related Aspects of Intellectual Property Rights (TRIPS); and H.R.4521, AmericaCOMPETES Act of 2022.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.